Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.41 USD | -3.05% | +4.24% | -56.89% |
May. 09 | Deutsche Bank Adjusts agilon health Price Target to $5 From $8, Maintains Hold Rating | MT |
May. 07 | Transcript : Agilon health, inc., Q1 2024 Earnings Call, May 07, 2024 |
Financials (USD)
Sales 2024 * | 6.17B | Sales 2025 * | 7.63B | Capitalization | 2.22B |
---|---|---|---|---|---|
Net income 2024 * | -142M | Net income 2025 * | -60M | EV / Sales 2024 * | 0.33 x |
Net cash position 2024 * | 187M | Net cash position 2025 * | 205M | EV / Sales 2025 * | 0.26 x |
P/E ratio 2024 * |
-15.4
x | P/E ratio 2025 * |
-37.6
x | Employees | 1,117 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 74.11% |
Latest transcript on agilon health, inc.
1 day | -3.05% | ||
1 week | +4.24% | ||
Current month | -1.64% | ||
1 month | +0.56% | ||
3 months | -23.91% | ||
6 months | -54.69% | ||
Current year | -56.89% |
Managers | Title | Age | Since |
---|---|---|---|
Veeral Desai
FOU | Founder | 43 | 15-12-31 |
Steven Sell
CEO | Chief Executive Officer | 57 | 20-05-31 |
Timothy Bensley
DFI | Director of Finance/CFO | 64 | 20-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Steven Sell
CEO | Chief Executive Officer | 57 | 20-05-31 |
Ronald Williams
FOU | Founder | 74 | 15-12-31 |
Sharad Mansukani
BRD | Director/Board Member | 54 | 16-12-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.94% | 8 M€ | +5.66% |
Date | Price | Change | Volume |
---|---|---|---|
24-05-17 | 5.41 | -3.05% | 5,008,797 |
24-05-16 | 5.58 | +5.28% | 4,772,042 |
24-05-15 | 5.3 | -3.64% | 2,104,346 |
24-05-14 | 5.5 | +5.57% | 6,427,643 |
24-05-13 | 5.21 | +0.39% | 4,646,541 |
Delayed Quote Nyse, May 17, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-56.89% | 2.22B | |
-20.57% | 2.95B | |
-16.01% | 2.84B | |
-37.78% | 268M | |
+5.57% | 235M | |
-40.04% | 196M | |
-36.31% | 110M |
- Stock Market
- Equities
- AGL Stock